Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clinical Isolated Syndrome (CIS)”

10 trials

Showing 10 of 10 results

Not applicableStudy completedNCT00617383
What this trial is testing

AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
The University of Texas Health Science Center, Houston 3
Not applicableEnded earlyNCT04599023
What this trial is testing

Assessing the Feasibility of the MSPT Device in Routine Clinical Practice in the Swiss Healthcare System

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
Insel Gruppe AG, University Hospital Bern 182
Not applicableStudy completedNCT03541226
What this trial is testing

Clinical Monitoring, MRI and Neuro-Ophthalmology of a Cohort of Patients With a Clinically Isolated Syndrome (CIS)

Who this might be right for
Clinically Isolated SyndromeMultiple Sclerosis
University Hospital, Lille 134
Not applicableStudy completedNCT01112657
What this trial is testing

An Observational Study on the Progression of Clinically Isolated Syndrome to Multiple Sclerosis Over a 2-year Period

Who this might be right for
Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 154
Not applicableEnded earlyNCT00819897
What this trial is testing

Longitudinal Study in Clinically Isolated Syndrome (CIS) Patients Treated With Interferon Beta

Who this might be right for
Clinically Isolated Syndrome
Centre Hospitalier Universitaire de Nice 37
Not applicableStudy completedNCT02076841
What this trial is testing

Tolerability and Quality of Life Study in Participants Who Switched to Avonex Pen

Who this might be right for
Relapsing-Remitting Multiple SclerosisClinical Isolated Syndrome (CIS)Multiple Sclerosis
Biogen 40
Post-approval studies (Phase 4)Study completedNCT02254304
What this trial is testing

Effectiveness of Rebif® in Clinically Isolated Syndrome and Relapsing Multiple Sclerosis Using RebiSmart™

Who this might be right for
Relapsing Multiple SclerosisClinically Isolated Syndrome
Merck KGaA, Darmstadt, Germany 106
Large-scale testing (Phase 3)Study completedNCT00725985
What this trial is testing

Oral Cladribine in Early Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
EMD Serono Research & Development Institute, Inc. 617
Large-scale testing (Phase 3)Study completedNCT00622700
What this trial is testing

Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 618
Not applicableStudy completedNCT01414816
What this trial is testing

Betaferon® Regulatory Post-Marketing Surveillance

Who this might be right for
Multiple SclerosisClinically Isolated System
Bayer 355

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation